Nephrology Perspective

• ACC 2025 Little Learned From Trials That Are Positive by Design Dapagliflozin after TAVI? Semaglutide for claudication? Two trials designed to be positive should not warrant new indications for these drugs writes John Mandrola, MD.
  theheart.org on Medscape, April 10, 2025
• Know SSRI Side Effects Dr. Paauw warns about common side effects of selective serotonin reuptake inhibitors that may be seen in primary care.
  Medscape Internal Medicine, April 10, 2025
• ACC 2025 Fluid Restriction in HF: Let’s Not Torture Patients   Drs Piña and Hsich discuss the FRESH-UP trial that challenged the dogma of fluid restriction in heart failure and provide practical strategies for optimizing medical therapy instead.
  theheart.org on Medscape, April 09, 2025
• Bladder Cancer e-Tumor Boards: Case 9: Metastatic Recurrent Urothelial Cancer   This case highlights a patient who initially presented with an advanced stage upper tract urothelial tumor, and he underwent a nephroureterectomy.
  Medscape, April 09, 2025
• The Management of Hypercalcemia in Primary Care   Primary hyperparathyroidism and malignancy account for around 90% of all cases of hypercalcemia in primary care.
  Medscape Family Medicine, April 09, 2025
• Bladder Cancer e-Tumor Boards: Case 8: Localized Muscle Invasive Bladder Cancer   This case highlights a patient with a small bladder mass who was also found to have incidental liver cirrhosis and other comorbid-type conditions.
  Medscape, April 09, 2025
• Bladder Cancer e-Tumor Boards: Case 7: Multifocal Muscle Invasive Bladder Cancer   This case highlights a patient with muscle invasive bladder cancer. Bladder preserving treatment approaches are discussed.
  Medscape, April 09, 2025
• Apr 04 2025 This Week in Cardiology   Trials from the 2025 American College of Cardiology scientific sessions, including the WARRIOR, PROTECT TAVI, DAPATAVI, and SOUL are reviewed by John Mandrola, MD
  theheart.org on Medscape, April 04, 2025
• Renal Denervation: Antihypertensive or Gizmo Idolatry? A hypertension expert's view of the current status of renal denervation for resistant hypertension.
  Journal of the American College of Cardiology, March 20, 2025
• Gene Therapy: Medical Progress Has a Price, Says Ethicist   Ethicist Art Caplan discusses progress in gene therapy research and the need for medical professionals and regulators to tolerate appropriate risk.
  Medscape Business of Medicine, April 01, 2025
• The Ethical Consequences of the New Administration   Ethicist Art Caplan discusses the ethical consequences of the new administration.
  Medscape Business of Medicine, March 27, 2025
• S3 Episode 3: The 2025 updates of the American Diabetes Association   Drs Carol H. Wysham and Rozalina G. McCoy discuss the 2025 updates of the American Diabetes Association, including comorbidities, dental care, sexual dysfunction, and CGM use.
  Medscape, March 25, 2025
• C3 Glomerulopathy: Diagnosing a Rare and Variable Disease   Nonspecific signs on a medical exam may point to C3 glomerulopathy, a rare disease with a variable course ranging from quiescence to rapidly progressive kidney failure, reports Dr Fernando Fervenza.
  Medscape, March 24, 2025
• Complement 3 Glomerulopathy: 5 Differentials to Know C3G, a rare kidney disease often associated with devastating progression, requires careful evaluation to distinguish it from other glomerulopathies. Here are five must-know differentials.
  Medscape Nephrology, March 24, 2025
• Immunosuppressive Therapies in C3 Glomerulopathy Medscape spoke with Andrew Bomback, MD, MPH, about the use of steroids, pegcetacoplan, and iptacopan in C3G.
  Medscape Nephrology, March 24, 2025
• European Doctors’ Sexual Harassment Report 2025 Healthcare systems in Europe still have far to go if they aim to keep doctors safe in the workplace.
  Medscape Features Slideshows, March 24, 2025
• Nonpharmacologic Management of Patients With HF A review of the optimal lifestyle recommendations including dietary interventions, exercise, and management of sleep-disordered breathing, mood disorders, and substance use.
  JACC: Heart Failure, March 20, 2025
• Ethicist Supports Assisted-Suicide Policies—With Safeguards   Ethicist Art Caplan discusses considerations regarding assisted-suicide laws.
  Medscape Business of Medicine, March 20, 2025
• Episode 2: New Guidelines and the Lupus Nephritis Kidney Conundrum   Join Drs Maureen McMahon and Brad Rovin as they discuss the KDIGO, ACR and EULAR guidelines as they relate to lupus nephritis.
  Medscape, March 20, 2025
• Episode 1: Lupus by the Numbers: What the Data Reveals   Join Drs Maureen McMahon and Peter Izmirly as they discuss lupus epidemiology, and why knowing the data is especially important for physicians on the frontlines of healthcare.
  Medscape, March 20, 2025